Pyridostigmine recalls

The FDA has published 3 recalls involving Pyridostigmine since 2013. The latest was reported on 2 Nov 2022. Most were for potency & assay. Corepharma has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2013

Last 12 months0reported

Class I00% of total

Ongoing0latest 2 Nov 2022

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why pyridostigmine is recalled

Potency & Assay3100%

Companies

By year

2022133%
2014133%
2013133%

All pyridostigmine recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
2 Nov 2022Drug	CLASS II	Pyridostigmine Bromide Oral Solution, USP 60 mg/ Delivers recalledPyridostigmine Bromide	VistaPharm	Potency & Assay	Nationwide
12 Feb 2014Drug	CLASS II	Pyridostigmine Bromide Tablets USP, 60 mg recalled by Corepharma	Corepharma	Potency & Assay	Nationwide
2 Oct 2013Drug	CLASS II	Pyridostigmine Bromide Tablets 60 mg recalled by Core Pharma	Core Pharma	Potency & Assay	Nationwide

Should you stop taking Pyridostigmine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.